Genelux (GNLX) Return on Capital Employed (2023 - 2026)

Genelux (GNLX) recorded quarterly Return on Capital Employed of 187.59% in Q1 2026, up 10.86% quarter-over-quarter from 210.45% in Q4 2025.

Genelux (GNLX) Return on Capital Employed (2023 - 2026) Analysis & Trends

Genelux's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 187.59% for Q1 2026.

  • In Q1 2026, Return on Capital Employed changed N/A year-over-year to 187.59%; the TTM figure through Mar 2026 stood at 187.59% (changed N/A YoY), while the FY2025 annual figure was 160.87%, down 3098.0% from the prior year.
  • Return on Capital Employed was 187.59% for Q1 2026 at Genelux, up from 210.45% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 77.88% in Q3 2024 to a low of 210.45% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 131.85% across 4 years, with a median of 121.66% in 2024.
  • The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 469 bps in 2024, then plunged 10684 bps in 2025.
  • A 4-year view of Return on Capital Employed shows it stood at 98.92% in 2023, then decreased by 5 bps to 103.62% in 2024, then slumped by 103 bps to 210.45% in 2025, then gained by 11 bps to 187.59% in 2026.
  • The last three Return on Capital Employed figures came in at 187.59% (Q1 2026), 210.45% (Q4 2025), and 142.82% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Genelux 129.36 Mn 129.36 Mn - -187.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -187.59%
Dec 31, 2025 -210.45%
Sep 30, 2025 -142.82%
Dec 31, 2024 -103.62%
Sep 30, 2024 -77.88%
Jun 30, 2024 -93.79%
Mar 31, 2024 -139.71%
Dec 31, 2023 -98.92%